WhiteNest Pharma announces an upcoming MDR inspection by KIWA Cermet for the BioNest 12D, BioNest 2.0, and BioNest Transfer systems on March 13-14. This pivotal review is expected to secure a new certification for these innovative systems, reinforcing our commitment… Leggi tutto »WHITENEST PHARMA ANTICIPATES MDR CERTIFICATION FOR BIONEST SYSTEMS
WhiteNest Pharma is excited to announce the completion of the planning phase for an innovative pharmaceutical plant dedicated to manufacturing lyophilized cord blood and adult blood platelets. This significant milestone paves the way for the production of high-value pharmaceutical applications,… Leggi tutto »WHITENEST PHARMA COMPLETES PROJECT PLANNING FOR INNOVATIVE PHARMACEUTICAL PLANT
WhiteNest Pharma is proud to announce a strategic collaboration with a prestigious university’s Pharmacological Sciences Department to enhance the formulation of Lysaderm, aiming at scalability for global markets while upholding the highest quality standards. This partnership signifies our dedication to… Leggi tutto »WHITENEST PHARMA INITIATES COLLABORATIVE RESEARCH TO ADVANCE LYSADERM’S FORMULATION